Summary: Pathologic visceral pleural invasion (VPI) in patients with early-stage lung cancer can result in the upstaging of T1 to T2, in addition to having implications for surgical resection and prognostic outcomes. This study was designed with the goal of establishing and validating a CT-based deep learning (DL) model capable of predicting VPI status and stratifying patients based on their prognostic outcomes. In total, 2077 patients from three centers with pathologically confirmed clinical stage IA lung adenocarcinoma were enrolled. DL signatures were extracted with a 3D residual neural network. DL model was able to effectively predict VPI status. VPI predicted by the DL models, as well as pathologic VPI, was associated with shorter dise...
To investigate the value of the deep learning method in predicting the invasiveness of early lung ad...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
Objective:We analyzed non-small cell lung cancer patient survival in our single institution database...
Objectives: The subtype classification of lung adenocarcinoma is important for treatment decision. T...
Purpose: Tumors are continuously evolving biological systems, and medical imaging is uniquely positi...
This study aims to develop a deep neural network (DNN)-based two-stage risk stratification model for...
Cho et al. use a radiomics-guided deep-learning approach to model the prognosis of lung adenocarcino...
BackgroundTo develop and validate a deep learning–based model on CT images for the malignancy and in...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...
BackgroundTumor invasiveness plays a key role in determining surgical strategy and patient prognosis...
Lung cancer has a high incidence and mortality rate. The five-year relative survival rate f...
PURPOSEPreoperative prediction of visceral pleural invasion (VPI) is important because it enables th...
PURPOSE: To develop and evaluate a deep learning (DL) approach to extract rich information from high...
BackgroundCheckpoint inhibitors provided sustained clinical benefit to metastatic lung cancer patien...
Lung cancer is the leading cause of cancer death worldwide. The critical reason for the deaths is de...
To investigate the value of the deep learning method in predicting the invasiveness of early lung ad...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
Objective:We analyzed non-small cell lung cancer patient survival in our single institution database...
Objectives: The subtype classification of lung adenocarcinoma is important for treatment decision. T...
Purpose: Tumors are continuously evolving biological systems, and medical imaging is uniquely positi...
This study aims to develop a deep neural network (DNN)-based two-stage risk stratification model for...
Cho et al. use a radiomics-guided deep-learning approach to model the prognosis of lung adenocarcino...
BackgroundTo develop and validate a deep learning–based model on CT images for the malignancy and in...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...
BackgroundTumor invasiveness plays a key role in determining surgical strategy and patient prognosis...
Lung cancer has a high incidence and mortality rate. The five-year relative survival rate f...
PURPOSEPreoperative prediction of visceral pleural invasion (VPI) is important because it enables th...
PURPOSE: To develop and evaluate a deep learning (DL) approach to extract rich information from high...
BackgroundCheckpoint inhibitors provided sustained clinical benefit to metastatic lung cancer patien...
Lung cancer is the leading cause of cancer death worldwide. The critical reason for the deaths is de...
To investigate the value of the deep learning method in predicting the invasiveness of early lung ad...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
Objective:We analyzed non-small cell lung cancer patient survival in our single institution database...